Tag Archives: Novartis

Novartis changes NICE's mind on Kymriah, giving CAR-T rival Gilead some company

Payer coverage is key to Novartis’ plan to get Kymriah going, and the company is going to be getting some more of that. England’s cost watchdog, the National Institute for Health and Care Excellence (NICE), has recommended the CAR-T med to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) through its Cancer… Read More »

Novartis, still struggling with Kymriah manufacturing, is providing some out-of-spec doses to patients who ask

Novartis released some new data on CAR-T drug Kymriah this month that it hopes will improve the uptake of the drug. But Novartis also continues to wrestle with manufacturing issues that have kept some doses from meeting specifications, a problem that is also hampering Kymriah sales. The drugmaker says it is working on a list… Read More »